RXO, Inc.
RXO · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $1,421 | $1,419 | $1,433 | $1,667 |
| % Growth | 0.1% | -1% | -14% | – |
| Cost of Goods Sold | $1,185 | $1,165 | $1,201 | $1,407 |
| Gross Profit | $236 | $254 | $232 | $260 |
| % Margin | 16.6% | 17.9% | 16.2% | 15.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $243 | $214 | $262 | $284 |
| Operating Expenses | $243 | $214 | $262 | $284 |
| Operating Income | -$7 | $40 | -$30 | -$24 |
| % Margin | -0.5% | 2.8% | -2.1% | -1.4% |
| Other Income/Exp. Net | -$8 | -$50 | -$9 | -$9 |
| Pre-Tax Income | -$15 | -$10 | -$39 | -$33 |
| Tax Expense | -$1 | -$1 | -$8 | -$8 |
| Net Income | -$14 | -$9 | -$31 | -$25 |
| % Margin | -1% | -0.6% | -2.2% | -1.5% |
| EPS | -0.08 | -0.053 | -0.18 | -0.12 |
| % Growth | -49.8% | 70.3% | -50% | – |
| EPS Diluted | -0.08 | -0.053 | -0.18 | -0.12 |
| Weighted Avg Shares Out | 169 | 169 | 168 | 164 |
| Weighted Avg Shares Out Dil | 169 | 169 | 168 | 164 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $9 | $8 | $9 | $8 |
| Depreciation & Amortization | $26 | $30 | $32 | $33 |
| EBITDA | $20 | $40 | $22 | $42 |
| % Margin | 1.4% | 2.8% | 1.5% | 2.5% |